Ben Lamm

Colossal Foundation Reaches $100M as Its 2025 Impact Report Spans AI-Decoded Wolf Howls to Keeping Species Off the Extinction List

by | Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE
‘There’s So Much Energy in Our Space’: Innovators, Investors Invigorate Sold-Out 2025 Venture Dallas Conference
by | Nov 5, 2025
From North Texas founders including John Carmack and Ben Lamm to investors like John Redgrave of DTX Ventures and Draper’s Andy Tang, the summit's speakers tackled hot topics from humanoid robots and tech transfer to AI, VC trends and Y’all Street. A call was also heard for more risk-taking by DFW’s innovation ecosystem: ‘We’ve got to be bravery hunters.’
MORE

Colossal Raises Another $120M, Announces Pigeon Cell Breakthrough to Help ‘De‑Extinct’ the Dodo

by | Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE
AGI and De-Extinction: John Carmack and Ben Lamm Join Venture Dallas 2025 Lineup
by | Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE

The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl

by | Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE
Who Made This Year’s AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence
by | Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE
Hear the Howl: Dallas De‑Extinction Company Colossal Biosciences Brings Back Dire Wolf Using Ancient DNA
by | Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species. Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE
Meet the Colossal Woolly Mouse, Created by Dallas-Based ‘Decacorn’ Colossal Biosciences
by | Mar 4, 2025
Before Colossal Biosciences can "de-extinct" the woolly mammoth, some small steps are in order. They've now been taken by the Colossal Woolly Mouse—a gene-edited creation with "dramatically altered coat color, texture, and thickness reminiscent of the woolly mammoth’s core phenotypes."
MORE

Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding

by | Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE
Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More
by | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE